Portrait of Johnson, Julie

Johnson, Julie

U.S. Representative TX-32 Democratic Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
585
Buys / sells
20% / 79%
Last trade
May 12, 2026
Last filing
Aug 5, 2026

Latest disclosed trades

Latest 10 of 585
Ticker Type Traded
ACN Sell May 12, 2026
ABT Sell May 12, 2026
FITB Exchange Feb 2, 2026
WFC Sell Dec 18, 2025
TJX Sell Dec 18, 2025
UNH Sell Dec 18, 2025
CMCSA Sell Dec 18, 2025
LLY Sell Dec 18, 2025
BK Sell Dec 18, 2025
APD Sell Dec 18, 2025

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Johnson, Julie stock trade activity

FilingIQ has indexed 585 congressional stock trade disclosures for Johnson, Julie. The most recent disclosed transaction is dated May 12, 2026.

Across the full history, 117 purchases and 464 sales have been disclosed under the STOCK Act.

Top tickers traded by Johnson, Julie

Frequently asked

How many stock trades has Johnson, Julie disclosed?
FilingIQ tracks 585 Periodic Transaction Report disclosures for Johnson, Julie, with the most recent dated May 12, 2026. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Johnson, Julie a net buyer or net seller?
Across the disclosed trade history, 117 (20%) were purchases and 464 (79%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Johnson, Julie come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.